<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02883257</url>
  </required_header>
  <id_info>
    <org_study_id>003/2016</org_study_id>
    <nct_id>NCT02883257</nct_id>
  </id_info>
  <brief_title>Clinical and Biological Markers of Response to Cognitive Behavioural Therapy for Depression</brief_title>
  <official_title>Clinical and Biological Markers of Response to Cognitive Behavioural Therapy for Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre for Addiction and Mental Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dalhousie University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre for Addiction and Mental Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to locate clinical markers (for example, interviews,
      questionnaires, and computer tasks) and biological markers (for example, physiological,
      blood-based, or electroencephalography measurements) that predict response to cognitive
      behavioral therapy for depression.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Forty adult outpatients with major depressive disorder or persistent depressive disorder will
      receive up to 20 sessions of cognitive behavioral therapy for depression over 16 weeks.
      Participants will complete clinical measures (interviews, questionnaires, and computer-based
      tasks) and biological measures (blood tests, physiological measurements,
      electroencephalography ) before, during, and after treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2016</start_date>
  <completion_date type="Actual">November 2017</completion_date>
  <primary_completion_date type="Actual">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Montgomery Asberg Depression Rating Scale</measure>
    <time_frame>16 weeks</time_frame>
    <description>Depression symptom severity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quick Inventory of Depressive Symptomatology (QIDS)</measure>
    <time_frame>16 weeks</time_frame>
    <description>Depression symptom severity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>World Health Organization Quality of Life Short Version (WHOQOL-BREF)</measure>
    <time_frame>16 weeks</time_frame>
    <description>Quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hamilton Depression Rating Scale (Ham-D)</measure>
    <time_frame>16 weeks</time_frame>
    <description>Depression symptom severity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Depression Inventory (BDI)</measure>
    <time_frame>16 weeks</time_frame>
    <description>Depression symptom severity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Work and Social Adjustment Scale (WSAS)</measure>
    <time_frame>16 weeks</time_frame>
    <description>Functioning and impairment</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Cognitive Behavioral Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 individual 60-minute appointments over the course of 16 weeks
Consistent with Beck, Rush, Shaw, and Emery (1979)</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioral Therapy</intervention_name>
    <description>Cognitive Behavioral Therapy will include core mandatory modules of key effective components (e.g., behavioural activation, cognitive restructuring) and optional elements to address individual maintaining factors (e.g., coping and social skills training, perfectionism and self-criticism).</description>
    <arm_group_label>Cognitive Behavioral Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of Major Depressive Disorder or Persistent Depressive Disorder
             according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition

          -  Must be fluent in English

          -  Must be capable to give informed consent

        Exclusion Criteria:

          -  Lifetime diagnosis of Schizophrenia, Schizoaffective Disorder, Bipolar Disorder

          -  Current Alcohol or Drug Use Disorder (except tobacco or caffeine)

          -  Current psychotic symptoms

          -  Acute suicide risk

          -  Psychological treatment for depression initiated during the past three months

          -  Pharmacological treatment for depression initiated/changed during the past three
             months

          -  Previous non-response to two or more adequate trials of pharmacotherapy

          -  Current significant neurological disorder, head trauma, or unstable medical
             conditions.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lena C Quilty, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre for Addiction and Mental Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre for Addiction and Mental Health</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T 1R8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://www.camh.ca/research</url>
    <description>Information about research at the Centre for Addiction and Mental Health</description>
  </link>
  <link>
    <url>http://www.canbind.ca</url>
    <description>Information about research by the Canadian Biomarker Integration Network in Depression</description>
  </link>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 19, 2016</study_first_submitted>
  <study_first_submitted_qc>August 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 30, 2016</study_first_posted>
  <last_update_submitted>April 19, 2018</last_update_submitted>
  <last_update_submitted_qc>April 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre for Addiction and Mental Health</investigator_affiliation>
    <investigator_full_name>Lena Quilty</investigator_full_name>
    <investigator_title>Independent Scientist</investigator_title>
  </responsible_party>
  <keyword>Major Depression</keyword>
  <keyword>Major Depressive Disorder</keyword>
  <keyword>Persistent Depressive Disorder</keyword>
  <keyword>Cognitive Behavioral Therapy</keyword>
  <keyword>Biomarkers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

